Frazier Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.5K Buy
905
+22
+2% +$1.39K 0.03% 188
2026
Q2
$50.9K Sell
883
-13
-1% -$746 0.03% 183
2026
Q1
$54.3K Buy
896
+674
+304% +$39.3K 0.03% 176
2025
Q4
$12K Buy
222
+69
+45% +$3.32K 0.01% 333
2025
Q3
$6.9K Hold
153
– – ﹤0.01% 411
2025
Q2
$7.08K Sell
153
-332
-68% -$16.3K 0.01% 405
2025
Q1
$29.6K Sell
485
-209
-30% -$12.2K 0.02% 199
2024
Q4
$38.9K Buy
694
+332
+92% +$18.6K 0.03% 158
2024
Q3
$18.7K Sell
362
-255
-41% -$12K 0.01% 267
2024
Q2
$25.6K Sell
617
-228
-27% -$10.2K 0.02% 248
2024
Q1
$45.8K Sell
845
-66
-7% -$3.36K 0.04% 160
2023
Q4
$46.7K Buy
+911
New +$47.8K 0.04% 143

Other funds holding BMY

Frazier Financial Advisors's BMY Position: Q3 2026 in Review

Frazier Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 2.5% in Q3 2026, buying an estimated $1.39K and bringing the position to 905 shares worth $56.5K. The position accounts for 0.03% of the portfolio, ranked #188.

Frazier Financial Advisors first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Frazier Financial Advisors held 905 shares of Bristol-Myers Squibb worth $56.5K as of Q3 2026.
  • Frazier Financial Advisors bought 22 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.39K.
  • Bristol-Myers Squibb made up 0.03% of Frazier Financial Advisors's portfolio in Q3 2026, its #188 holding.
  • Frazier Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
  • 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Frazier Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.